Monika Kutyna

Monika Kutyna

Adelaide Medical School

Faculty of Health and Medical Sciences

I am an early career postdoctoral researcher with an emerging track record, on a trajectory to establish myself as an independent investigator in the field of bone marrow microenvironment research. My project focuses on the role of bone marrow microenvironment in the pathogenesis of myeloid neoplasms where I developed complex in vtiro assays to study mesenchymal stromal cell (MSC) and drug targeting using primary cells. I also established a repository of biospecimens (MSC, bone marrow and blood mononuclear cells) from patients with myeloid neoplasms and age-matched controls. I am also instrumental in contributing to the South Australian Myeloid Neoplasms (SA-MN) Registry by correlating experimental data with patient clinical information (i.e. treatment history, family history) and outcomes.

Therapy-related myeloid neoplasms (t-MN) are poorly understood blood cancers associated with extremely poor clinical outcomes causing early death in otherwise long-term cancer survivors. It accounts for ~20% of cases of myeloid neoplasms and is expected to rise by 2035 due to the increased use of chemotherapy and improved survival of cancer patients (Leukemia Foundation).The current paradigm ignores the contribution of aberrant bone marrow microenvironment and myeloid neoplasms are considered primarily to be haematopoietic stem cells (HSC) autonomous disorders, in which initiation and progression are mainly driven by HSC intrinsic genetic events.

Therefore, my project focuses on the role of bone marrow microenvironment in the pathogenesis of myeloid neoplasms, speciffically t-MN,  where I developed complex in vtiro assays to study mesenchymal stromal cell (MSC) and drug targeting using primary cells. I also established a repository of biospecimens (MSC, bone marrow and blood mononuclear cells) from patients with myeloid neoplasms and age-matched controls. 

  • Journals
    Year Citation
    2025 Wiseman, T., Spooner, M., Khanna, S., Hung, K., Toop, C., Kutyna, M. M., . . . Hiwase, D. K. (2025). RBC Transfusion Dependency Refines the Molecular International Prognostic Scoring System for Myelodysplastic Syndrome.. Blood advances, bloodadvances.2025016086.
    DOI
    2025 Shah, M. V., Hung, K., Baranwal, A., Wechalekar, G., Al-Kali, A., Toop, C. R., . . . Hiwase, D. (2025). Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort. Blood Cancer Journal, 15(1), 11 pages.
    DOI
    2025 Kok, C. H., Al-Kali, A., Thomas, D., He, R., Kutyna, M. M., Alkhateeb, H. B., . . . Hiwase, D. K. (2025). RAS Mutation Identifies a Poor Prognostic Molecular Subtype of Therapy-Related Myeloid Neoplasm.. Blood advances, bloodadvances.2025016374.
    DOI
    2025 Gharaee, N., Wegrzyn-Woltosz, J., Jiang, J., Akhade, V. S., Bridgers, J., Stubbins, R. J., . . . Karsan, A. (2025). Haploinsufficiency of miR-143 and miR-145 reveal targetable dependencies in resistant del(5q) myelodysplastic neoplasm: MECHANISMS OF RESISTANCE. Leukemia, 39(4), 917-928.
    DOI
    2025 Shah, M. V., Hung, K., Baranwal, A., Kutyna, M. M., Al-Kali, A., Toop, C., . . . Hiwase, D. K. (2025). Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations.. Blood advances, bloodadvances.2024015238.
    DOI Europe PMC1
    2024 Walker, H. N., Caly, L., Savic, I., Aziz, A., Tran, T., Whitley, M., . . . Lim, C. K. (2024). Recovery of yellow fever virus whole genome from an individual with severe vaccine-associated viscerotropic disease. Lancet Microbe, 5(5), e414.
    DOI Scopus1
    2024 Gaborit, L., Kalyanasundaram, K., Vu, J., Basam, A., Elhadi, M., Wright, D., . . . Larkin, M. (2024). Patterns of opioid use after surgical discharge: a multicentre, prospective cohort study in 25 countries. Anaesthesia, 79(9), 924-936.
    DOI Scopus5 Europe PMC5
    2024 Melin, J., Forslund, M., Alesi, S., Piltonen, T., Romualdi, D., Spritzer, P. M., . . . Mousa, A. (2024). Response to Letter to the Editor from de Zegher and Ibáñez: 'Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis'.. J Clin Endocrinol Metab, 109(10), e1980-e1981.
    DOI
    2024 Isler, B., Niessen, N., Campbell, D., Toms, A. D., Daneman, N., Manning, L., & Davis, J. S. (2024). Addressing important evidence gaps in the management of prosthetic joint infection: clinician attitudes and equipoise. ANZ Journal of Surgery, 94(7-8), 1211-1213.
    DOI
    2024 Wechalekar, M. D., Zhao, L. -P., Kutyna, M. M., Hong, L. E., Li, J., Hung, K., . . . Hiwase, D. K. (2024). Myeloid neoplasms arising after methotrexate therapy for autoimmune rheumatological diseases do not exhibit poor-risk molecular features. Blood Cancer Journal, 14(1), 116-1-116-5.
    DOI Scopus1 Europe PMC1
    2024 Lim, K., Kan, W. L., Nair, P. C., Kutyna, M., Lopez, A. F., Hercus, T., . . . Thomas, D. (2024). CBL mutations in chronic myelomonocytic leukemia often occur in the RING domain with multiple subclones per patient: Implications for targeting. PLoS One, 19(9), e0310641-1-e0310641-19.
    DOI
    2024 Singhal, D., Kutyna, M. M., Hahn, C. N., Shah, M. V., & Hiwase, D. K. (2024). Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant Microenvironment. BLOOD CANCER DISCOVERY, 5(6), 400-416.
    DOI Scopus5 Europe PMC4
    2024 Wood, A. J., Boyle, J. A., Barr, E. L. M., Barzi, F., Hare, M. J. L., Titmuss, A., . . . Maple-Brown, L. J. (2024). Corrigendum to “Type 2 diabetes after a pregnancy with gestational diabetes among first nations women in Australia: The PANDORA study” [Diabetes Res. Clin. Pract. 181 (2021) 109092] (Diabetes Research and Clinical Practice (2021) 181, (S0168822721004514), (10.1016/j.diabres.2021.109092)). Diabetes Research and Clinical Practice, 213, 2 pages.
    DOI
    2024 Tate, K., Penconek, T., Booth, A., Harvey, G., Flynn, R., Lalleman, P., . . . Jones, K. (2024). Contextually appropriate nurse staffing models: A realist review protocol. BMJ Open, 14(5), 9 pages.
    DOI Scopus1
    2024 Hong, L. E., Wechalekar, M. D., Kutyna, M. M., Small, A., Lim, K., Thompson-Peach, C. A., . . . Hiwase, D. K. (2024). IDH-Mutant Myeloid Neoplasms are Associated with Seronegative Rheumatoid Arthritis and Innate Immune Activation. Blood, 143(18), 1873-1877.
    DOI Scopus5 Europe PMC2
    2024 Miwa, A., Wakamori, M., Ariyoshi, T., Okada, Y., Shirouzu, M., Umehara, T., & Kamiya, K. (2024). Efficiency of transcription and translation of cell-free protein synthesis systems in cell-sized lipid vesicles with changing lipid composition determined by fluorescence measurements. Scientific Reports, 14(1), 10 pages.
    DOI Scopus5 Europe PMC2
    2023 Luo, S., Png, G. K., Ostle, N. J., Zhou, H., Hou, X., Luo, C., . . . Bardgett, R. D. (2023). Grassland degradation-induced declines in soil fungal complexity reduce fungal community stability and ecosystem multifunctionality. SOIL BIOLOGY & BIOCHEMISTRY, 176, 12 pages.
    DOI
    2023 Bakhai, M. P., & Rifat, A. H. (2023). Design and Analysis of Generic UAV Composite Winglet Structures. Journal of the Institution of Engineers India Series C, 104(5), 967-977.
    DOI Scopus2
    2023 Thomas, D., Wu, M., Nakauchi, Y., Zheng, M., Thompson-Peach, C. A., Lim, K., . . . Majeti, R. (2023). Dysregulated lipid synthesis by oncogenic IDH1 mutation is a targetable synthetic lethal vulnerability. Cancer Discovery, 13(2), 496-515.
    DOI Scopus37 WoS7 Europe PMC29
    2023 Kutyna, M. M., Loone, S., Saunders, V. A., White, D. L., Kok, C. H., & Hiwase, D. K. (2023). Solute Carrier Family 29A1 Mediates In Vitro Resistance to Azacitidine in Acute Myeloid Leukemia Cell Lines. International Journal of Molecular Sciences, 24(4), 3553-1-3553-14.
    DOI Scopus3
    2023 Hiwase, D. K., Hahn, C. N., Tran, E. N. H., Chhetri, R., Baranwal, A., Al-Kali, A., . . . Shah, M. V. (2023). TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype. Blood, 141(9), 1087-1091.
    DOI Scopus21 WoS7 Europe PMC19
    2023 Eadie, L. N., Rehn, J. A., Schutz, C. E., Heatley, S. L., Kutyna, M. M., Hiwase, D. K., . . . Yeung, D. T. (2023). Case report: Rare case of donor cell-derived T-cell acute lymphoblastic leukaemia in a female patient after receiving an allo-transplant from her male sibling. British Journal of Haematology, 203(2), 282-287.
    DOI Europe PMC1
    2023 Sharplin, K., Proudman, W., Chhetri, R., Tran, E. N. H., Choong, J., Kutyna, M., . . . Hiwase, D. (2023). A Personalized Risk Model for Azacitidine Outcome in Myelodysplastic Syndrome and Other Myeloid Neoplasms Identified by Machine Learning Model Utilizing Real-World Data. Cancers, 15(16), 1-14.
    DOI Scopus3 Europe PMC2
    2022 Kutyna, M. M., Kok, C. H., Lim, Y., Campbell, D., Paton, S., Thompson-Peach, C. A. L., . . . Hiwase, D. (2022). Senolytic Therapy Can Reverse Senescent Bone Marrow Stroma of Therapy-Related Myeloid Neoplasm. Blood, 140(Supplement 1), 9755-9756.
    DOI
    2022 Kutyna, M. M., Kok, C. H., Lim, Y., Tran, E. N. H., Campbell, D., Paton, S., . . . Hiwase, D. K. (2022). A senescence stress secretome is a hallmark of therapy-related myeloid neoplasm stromal tissue occurring soon after cytotoxic exposure. Leukemia, 36(11), 2678-2689.
    DOI Scopus15 WoS4 Europe PMC13
    2022 Shah, M., Hahn, C. N., Tran, E. N. H., Sharplin, K. M., Chhetri, R., Baranwal, A., . . . Hiwase, D. (2022). <i>TP53</i> Mutation Status Defines a Distinct Clinicopathological Entity of Therapy-Related Myeloid Neoplasm, Characterized By Genomic Instability and Extremely Poor Outcome. BLOOD, 140(Supplement 1), 9798-9799.
    DOI
    2021 Singhal, D., Hahn, C. N., Feurstein, S., Wee, L. Y. A., Moma, L., Kutyna, M. M., . . . Hiwase, D. K. (2021). Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer. Leukemia, 35(11), 3245-3256.
    DOI Scopus45 WoS26 Europe PMC37
    2021 Weigelt, A., Mommer, L., Andraczek, K., Iversen, C. M., Bergmann, J., Bruelheide, H., . . . McCormack, M. L. (2021). An integrated framework of plant form and function: the belowground perspective. NEW PHYTOLOGIST, 232(1), 42-59.
    DOI Europe PMC108
    2020 Kutyna, M. M., Wee, L. Y. A., Paton, S., Cakouros, D., Arthur, A., Chhetri, R., . . . Hiwase, D. K. (2020). Therapy-Related Myeloid Neoplasm Has a Distinct Pro-Inflammatory Bone Marrow Microenvironment and Delayed DNA Damage Repair. Blood, 136(Supplement 1), 37-38.
    DOI
    2019 Chhetri, R., Wee, L. Y. A., Sinha, R., Kutyna, M. M., Pham, A., Stathopoulos, H., . . . Hiwase, D. K. (2019). Red cell autoimmunization and alloimmunization in myelodysplastic syndromes: Prevalence, characteristic and significance. Haematologica, 104(10), E451-E454.
    DOI Scopus18 WoS12 Europe PMC6
    2019 Singhal, D., Wee, L. Y. A., Kutyna, M. M., Chhetri, R., Geoghegan, J., Schreiber, A. W., . . . Hiwase, D. K. (2019). The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution. Leukemia, 33(12), 2842-2853.
    DOI Scopus48 WoS38 Europe PMC35
    2017 Hiwase, D., Singhal, D., Strupp, C., Chhetri, R., Kutyna, M., Wee, L., . . . Germing, U. (2017). Dynamic assessment of RBC-transfusion dependency improves the prognostic value of the revised-IPSS in MDS patients. American Journal of Hematology, 92(6), 508-514.
    DOI Scopus34 WoS24 Europe PMC17
    2017 Singhal, D., Kutyna, M. M., Chhetri, R., Wee, L. Y. A., Hague, S., Nath, L., . . . Hiwase, D. K. (2017). Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome. Haematologica, 102(12), 2021-2029.
    DOI Scopus48 WoS31 Europe PMC28
    2014 Hiwase, D. K., Hahn, C. N., Babic, M., Moore, S., Butcher, C. M., Kutyna, M. M., . . . Scott, H. S. (2014). Clonal Diversity of Recurrently Mutated Genes in Myelodysplastic Syndromes. BLOOD, 124(21), 3 pages.
    1987 Fabry, M. E., Kaul, D. K., Davis, L., Gore, J. C., Brown, M., & Nagel, R. L. (1987). An animal model for sickle cell vaso-occlusion: a study using NMR and technetium imaging.. Progress in Clinical and Biological Research, 240, 297-304.
    Scopus8 Europe PMC5
    1985 Desai, M. H., Brown, M., & Mlcak, R. (1985). Reduction of smoke-induced lung injury with dimethylsulfoxide and heparin treatment. Surgical Forum, VOL. 36, 103-104.
    Scopus12

  • Book Chapters
    Year Citation
    2024 Anikeeva, O., & Bi, P. (2024). Population health perspective on extreme weather events and emergency medical services. In J. Braithwaite, Y. Zurynski, & C. Smith (Eds.), Routledge Handbook of Climate Change and Health System Sustainability (pp. 133-140). Routledge.
    DOI

  • Conference Papers
    Year Citation
    2024 Kamel, M. M., Robinson, N., Kutyna, M., Lim, K., Thompson-Peach, C., Lane, S. W., . . . Thomas, D. (2024). High Dose Ascorbate Reduces Interleukin-1 Beta Secretion in TET2 Mutant Monocytes and Demonstrates Excellent and in CMML Patients in Combination with Azacitidine. In BLOOD Vol. 144 (pp. 1817-1818). ELSEVIER.
    DOI
    2024 Kutyna, M., Thomas, D., & Hiwase, D. (2024). Impact of Chronic Inflammation and Cytotoxic Therapy on Bone Marrow Microenvironment of Patients with Autoimmune Rheumatic Diseases and Myeloid Neoplasms. In BLOOD Vol. 144 (pp. 1304-1305). ELSEVIER.
    DOI
    2024 Lim, K., Kutyna, M., Kan, W., Lopez, A. F., Brown, A., Yong, A. S. M., . . . Thomas, D. (2024). CBL Variants in Chronic Myelomonocytic Leukemia Exhibit a Complex Sub-Clone Architecture with a High Frequency of RING Domain Mutations Sufficient to Induce GM-CSF Hypersensitivity. In BLOOD Vol. 144 (pp. 3196-3197). ELSEVIER.
    DOI
    2024 Wechalekar, G., Cibich, A., Kutyna, M., Shanmuganathan, N., Sekaran, U. C., Singhal, D., . . . Hiwase, D. (2024). Clonal Architecture of Donor-Derived Leukemia/Clonal Hematopoiesis after Allogeneic Hematopoietic Stem Cell Transplant. In BLOOD Vol. 144 (pp. 4928-4929). FL, Orlando: ELSEVIER.
    DOI
    2024 Pratiwi, G. R., Gunawan, I., Agustiani, N., Margaret, S., & Widowati, L. R. (2024). Upland Rice Productivity Affected by Some Ameliorants in Two Different Soil Types with Al Problem. In Aip Conference Proceedings Vol. 2957 (pp. 100013). AIP Publishing.
    DOI
    2024 Prawestri, A. D., Handayani, T., Leksonowati, A., Riastiwi, I., Gunawan, I., & Ridwan. (2024). Agronomic Traits and Leaves Nutritional Content Variation of Indonesian Moringa (Moringa oleifera Lam.). In Aip Conference Proceedings Vol. 2957 (pp. 040028). AIP Publishing.
    DOI
    2024 Shah, M., Hung, K., Baranwal, A., Price, Z., Al-Kali, A., Toop, C., . . . Hiwase, D. (2024). The 66th ASH Annual Meeting Abstract Abstracts. In BLOOD Vol. 144 (pp. 3214). ELSEVIER.
    2024 Hiwase, D., Price, Z., Kok, C. H., Kutyna, M., Singhal, D., Shanmuganathan, N., . . . Scott, H. S. (2024). Pathogenic Germline Variants in the DNA Damage Repair Pathway Are Enriched in Patients with Hematologic Malignancies with Prior Exposure to Cytotoxic Therapies Compared to Patients with Multiple Cancers without Prior Exposure. In BLOOD Vol. 144 (pp. 4596-4597). FL, Orlando: ELSEVIER.
    DOI
    2023 Susanto, U., Lestari, P., Rohaeni, W. R., & Gunawan, I. (2023). Thermogradient-Base Screening Technique for Evaluating High-Temperature Tolerance in Rice Genotypes during the Early Growth Stage. In Aip Conference Proceedings Vol. 2972 (pp. 060010). AIP Publishing.
    DOI
    2023 Gunawan, I., & Muhroji. (2023). Analysis of the HOTS mathematics learning evaluation questions for elementary schools. In Aip Conference Proceedings Vol. 2727 (pp. 020068). AIP Publishing.
    DOI
    2022 Shah, M., Hahn, C. N., Chhetri, R., Tran, E. N. H., Singhal, D., Hogan, W. J., . . . Hiwase, D. (2022). Integrated Personalized Prediction Model Identifies a Subgroup of Wild-Type TP53therapy-Related Myeloid Neoplasm Patients with Poor Outcome. In BLOOD Vol. 140 (pp. 6964-6965). LA, New Orleans: ELSEVIER.
    DOI
    2021 Chhetri, R., Sharplin, K., Proudman, W., Kutyna, M. M., Nayar, S., Singhal, D., . . . Hiwase, D. (2021). Hypomethylating Therapy Does Not Improve Outcome of Therapy-Related Myeloid Neoplasm Including TP53 Mutated and Complex Karyotype SubgroupsHypomethylating Therapy Does Not Improve Outcome of Therapy-Related Myeloid Neoplasm Including TP53 Mutated and Complex Karyotype Subgroups. In BLOOD Vol. 138 (pp. 3702-+). GA, Atlanta: ELSEVIER.
    DOI WoS3
    2021 Kutyna, M. M., Kok, C. H., Paton, S., Cakouros, D., Arthur, A., Hughes, T. P., . . . Hiwase, D. (2021). Distinct Senescent Bone Marrow Microenvironment in Therapy-Related Myeloid Neoplasms. In BLOOD Vol. 138 (pp. 4 pages). GA, Atlanta: AMER SOC HEMATOLOGY.
    DOI WoS1
    2021 Shah, M. V., Chhetri, R., Durani, U., Kutyna, M., Alkhateeb, H. B., Litzow, M. R., . . . Hiwase, D. (2021). T-MDS Is a Distinct Clinical and Pathological Entity Characterized By Better Survival Compared to t-AML. In BLOOD Vol. 138 (pp. 4 pages). GA, Atlanta: ELSEVIER.
    DOI
    2021 Hahn, C. N., Feurstein, S. K., Singhal, D., Kutyna, M. M., Chhetri, R., Wee, A., . . . Hiwase, D. (2021). Unexpected High Frequency of Pathogenic Germline Variants in Older Adults with Primary Myelodysplastic Syndrome. In BLOOD Vol. 138 (pp. 4 pages). GA, Atlanta: ELSEVIER.
    DOI WoS1
    2021 Choong, J., Kutyna, M. M., Chhetri, R., Moore, S., & Hiwase, D. (2021). Frequency of Chromosomal Translocations Are Significantly Higher in Therapy Related Myeloid Neoplasm As Compared to Primary MDS. In BLOOD Vol. 138 (pp. 3 pages). GA, Atlanta: ELSEVIER.
    DOI WoS1
    2021 Hainsworth, J., Friedman, C. F., Kurzrock, R., Spigel, D. R., Burris, H., Sweeney, C. J., . . . Swanton, C. (2021). Efficacy of atezolizumab in the treatment of solid tumors with high tumor mutational burden (TMB): A MyPathway study cohort.. In CANCER RESEARCH Vol. 81 (pp. 2 pages). PA, Philadelphia: AMER ASSOC CANCER RESEARCH.
    2020 Geng, J. -H., Pomerantz, M., Penney, K., Nabi, J., Sweeney, C., Mucci, L., & Kibel, A. (2020). IMPACT OF METABOLIC DISEASES AND DRUGS ON PROSTATE CANCER PATIENTS RECEIVING ANDROGEN DEPRIVATION THERAPY. In JOURNAL OF UROLOGY Vol. 203 (pp. E1222-E1223). DC, Washington: LIPPINCOTT WILLIAMS & WILKINS.
    2019 Singhal, D., Hahn, C. N., Moma, L. D., Wee, L. Y. A., Chhetri, R., Babic, M., . . . Hiwase, D. K. (2019). Deleterious Germline Variants, Especially in the DNA Repair Pathway, Are Common in Patients with Non-Related Multiple Cancers, One of Them Being Hematological Malignancy. In BLOOD Vol. 134 (pp. 3 pages). Orlando, FL: AMER SOC HEMATOLOGY.
    DOI WoS1
    2018 Bryce, A. H., Chen, Y. -H., Liu, G., Carducci, M. A., Jarrard, D. F., Garcia, J. A., . . . Sweeney, C. (2018). Patterns of PSA versus clinically progressive disease in the E3805 CHAARTED trial.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 36 (pp. 2 pages). AMER SOC CLINICAL ONCOLOGY.
    DOI
    2018 Komura, K., Sweeney, C., Inamoto, T., Ibuki, N., Azuma, H., & Kantoff, P. (2018). DNA REPLICATION STRESS BY THE LOSS OF MALE SPECIFIC HISTONE DEMETHYLASE 'KDM5D' IN AGGRESSIVE PROSTATE CANCER. In JOURNAL OF UROLOGY Vol. 199 (pp. E365). CA, San Francisco: ELSEVIER SCIENCE INC.
    2018 Allott, E., Noonan, E., Gonzalez-Feliciano, A., Markt, S., Wilson, K., Ahearn, T., . . . Mucci, L. (2018). MOLECULAR TUMOR PROFILING TO IDENTIFY MECHANISMS LINKING STATINS WITH LOWER RISK OF LETHAL PROSTATE CANCER. In JOURNAL OF UROLOGY Vol. 199 (pp. E261-E262). CA, San Francisco: ELSEVIER SCIENCE INC.
    2018 Oguntola, I., Olubeko, S., & Sweeney, C. (2018). SlimNets: An Exploration of Deep Model Compression and Acceleration. In 2018 IEEE HIGH PERFORMANCE EXTREME COMPUTING CONFERENCE (HPEC) (pp. 6 pages). MA, Waltham: IEEE.
    2017 Singhal, D., Wee, A., Parker, W., Moore, S., Babic, M., Feng, J., . . . Hiwase, D. K. (2017). Presence of Rare Germline Variants in Fanconi Anaemia Pathway Genes Confers a Poor Prognosis Comparable to <i>TP53</i> Mutations in Therapy-Related Myeloid Neoplasms. In BLOOD Vol. 130 (pp. 3 pages). Atlanta, GA: AMER SOC HEMATOLOGY.
    WoS2
    2017 Hahn, C. N., Wee, A., Babic, M., Feng, J., Wang, P., Kutyna, M. M., . . . Scott, H. S. (2017). Duplication on Chromosome 14q Identified in Familial Predisposition to Myeloid Malignancies and Myeloproliferative Neoplasms. In BLOOD Vol. 130 (pp. 2 pages). Atlanta, GA: AMER SOC HEMATOLOGY.
    WoS2
    2016 Singhal, D., Strupp, C., Chhetri, R., Kutyna, M., Wee, L., Nath, S., . . . Germing, U. (2016). RBC-transfusion dependency improves the prognostic value of the revised-IPSS in MDS patients: analysis of South Australian and Dusseldorf MDS registries. In Proceedings of the 58th Annual Meeting and Exposition of the American Society of Hematology, as published in Blood Vol. 128 (pp. 1998). San Diego, CA: American Society of Hematology.
    2016 Singhal, D., Strupp, C., Chhetri, R., Kutyna, M. M., Wee, L. A., Nath, S. V., . . . Germing, U. (2016). RBC-Transfusion Dependency Improves the Prognostic Value of the Revised-IPSS in MDS Patients: Analysis of South Australian and Dusseldorf MDS Registries. In BLOOD Vol. 128 (pp. 6 pages). San Diego, CA: AMER SOC HEMATOLOGY.
    2016 Singhal, D., Wee, L. A., Parker, W. T., Moore, S., Babic, M., Feng, J., . . . Hiwase, D. K. (2016). The Frequency of Genetic Mutations in T-MN Is High and Comparable to Primary MDS but the Spectrum Is Different. In BLOOD Vol. 128 (pp. 5 pages). San Diego, CA: AMER SOC HEMATOLOGY.
    DOI
    2015 Hahn, C. N., Babic, M., Schreiber, A. W., Kutyna, M. M., Wee, L. A., Brown, A. L., . . . Hiwase, D. (2015). Rare and Common Germline Variants Contribute to Occurrence of Myelodysplastic Syndrome. In BLOOD Vol. 126 (pp. 4 pages). Orlando, FL: AMER SOC HEMATOLOGY.
    DOI WoS3
    2013 Hiwase, D. K., Kutyna, M. M., Chhetri, R., Howell, S., Harrison, P. B., Nath, S. V., . . . To, L. B. (2013). Transfusion Dependency Is Associated With Inferior Survival Even In Very Low and Low Risk IPSS-R Patients. In BLOOD Vol. 122 (pp. 2 pages). New Orleans, LA: AMER SOC HEMATOLOGY.
    DOI WoS4

  • Conference Items
    Year Citation
    2019 Kutyna, M. M., Wee, A., Paton, S., Cakouros, D., Arthur, A., Chhetri, R., . . . Hiwase, D. K. (2019). Aberrant Bone Marrow Microenvironment in Therapy Related Myeloid Neoplasm (t-MN). Poster session presented at the meeting of BLOOD. Orlando, FL: AMER SOC HEMATOLOGY.
    DOI WoS2
    2018 Singhal, D., Wee, A., Kutyna, M. M., Babic, M., Chhetri, R., Parker, W., . . . Hiwase, D. K. (2018). Therapy-Related Myeloid Neoplasms (T-MN) and Primary MDS (PMDS) Patients with Very Low (VL) or Low (L) IPSS-R Score Share Clinical and Biological Characteristics and Have Similar Outcome. Poster session presented at the meeting of BLOOD. CA, San Diego: AMER SOC HEMATOLOGY.
    DOI
    2018 Chhetri, R., Wee, A., Sinha, R., Kutyna, M. M., Gupta, S., Nath, L., . . . Hiwase, D. K. (2018). Red Cell Alloimmunisation Is Associated with Increased Red Cell Transfusion Requirements in Myelodysplastic Syndrome. Poster session presented at the meeting of BLOOD. San Diego, CA: AMER SOC HEMATOLOGY.
    DOI WoS1
    2017 Singhal, D., Wee, L. A., Babic, M., Parker, W., Moore, S., Feng, J., . . . Hiwase, D. (2017). THERAPY RELATED MYELOID NEOPLASMS (T-MN) SHOW HIGH MUTATION FREQUENCY AND A SPECTRUM DIFFERENT FROM PRIMARY MDS. Poster session presented at the meeting of LEUKEMIA RESEARCH. Valencia, SPAIN: PERGAMON-ELSEVIER SCIENCE LTD.
    DOI
    2014 Hiwase, D. K., Singhal, D., Chhetri, R., Kutyna, M. M., Harrison, P. B., Nath, S. V., . . . To, L. B. (2014). Inclusion of RBC-Transfusion Dependency Can Improve the Prognostic Value of Revised-IPSS in MDS Patients. Poster session presented at the meeting of BLOOD. San Francisco, CA: AMER SOC HEMATOLOGY.

  • Preprint
    Year Citation
    2024 Munn, Z., & Moore, L. (2024). Views and opinions regarding e-cigarettes and vaping: a focus group study in South Australia.
    DOI
    2023 Hong, L. E., Wechalekar, M. D., Kutyna, M. M., Small, A., Lim, K., Thompson-Peach, C., . . . Hiwase, D. K. (2023). Seronegative Rheumatoid Arthritis and Innate Immune Activation is Frequent in Myeloid Neoplasms with Isocitrate Dehydrogenase 1/2 Mutations.
    DOI

Faculty of Health Sciences Divisional Scholarship and Dawes Supplementary Scholarship

Connect With Me
External Profiles